Vol. 28, Issue 8, 1007-1007, August 2000
ERRATUM
Drug Metabolism and Disposition 28: 608
Hartley
DP and Klaassen CD (2000) Detection of chemical-induced differential
expression of rat hepatic cytochrome P450 mRNA transcripts using
branched DNA signal amplification technology. Drug Metab
Dispos 28:608-616.
Figures 1 and 2 in the aforementioned article were mistakenly printed
in black and white. The correct figures (in color)
follow:

View larger version (110K):
[in this window]
[in a new window]
|
Fig. 1.
Two-dimensional illustration of the
multimeric complex formed with a target mRNA transcript during the bDNA
signal amplification assay.
The drawing is a representation of the final complex formed in the
assay. The long solid black line represents the single-stranded mRNA
target, blue lines represent capture probes, red lines represent label
probes, and green lines represent blocker probes. Oligonucleotides
complementary to the tail of the capture probes are shown as short
black bars attached to the solid support phase. The bDNA molecule
(light blue), with its 15 branch points, is shown hybridized to the
tail of the label probe. Alkaline phosphatase (AP; red diamonds)
conjugated oligonucleotides (orange) are shown hybridized to the
branches of the bDNA molecule (3 AP-oligonucleotide conjugate
molecules/branch). The signal generated by AP-mediated dioxetane
chemiluminescence is shown in yellow.
|
|

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
Schematic mapping the location and function
of individual oligonucleotide probes to individual CYP transcripts.
Each single-stranded CYP mRNA transcript is represented by a black
line, blocker probes are represented by green lines, capture probes are
represented by blue lines, label probes are represented by red lines,
and gaps in the probe set are indicated by arrows and the nucleotide
position at which the gap occurs.
|
|
0090-9556/00/2808-1007-1007$03.00/0
DRUG METABOLISM AND DISPOSITION
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics